Currently out of the existing stock ratings of Elliot Wilbur, 113 are a BUY (84.96%), 20 are a HOLD (15.04%).

Elliot Wilbur

Work Performance Price Targets & Ratings Chart

Analyst Elliot Wilbur, currently employed carries an average stock price target met ratio of 40.66% that have a potential upside of 30.92% achieved within 207 days. Previously, Elliot Wilbur worked at RAYMOND JAMES.

Elliot Wilbur’s has documented 216 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on SLGL, Sol Gel Technologies Ltd at 11-Aug-2023.

Wall Street Analyst Elliot Wilbur

Analyst best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS, . COMMON STOCK).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS, . COMMON STOCK) at 11/7/2019. The price target of $4 was fulfilled within 26 days with a profit of $1.35 (50.94%) receiving and performance score of 19.59.

Average potential price target upside

of $41.43 (29.71%) on AGN (ALLERGAN PLC).
of $25.47 (65.06%) on PTX (PERNIX THERAPEUTICS HOLDINGS).
of $23 (14.86%) on ZTS (ZOETIS).

ADMP Adamis Pharma AGN Allergan plc AKRX Akorn ANIP ANI Pharmaceuticals ATRS Antares Pharma FLXN Flexion Therapeutics MNK Mallinckrodt plc MYL Viatris PLXP PLx Pharma PRGO Perrigo Company PLC PTX Pernix Therapeutics Holdings SGNT Sagent Pharmaceuticals SLGL Sol Gel Technologies Ltd TEVA Teva Pharma Industries Ltd ADR ADMA ADMA Biologics AMRX Amneal Pharmaceuticals, . Common Stock CVET Covetrus PETQ PetIQ PYPD PolyPid VTRS Viatris ZTS Zoetis AERI Aerie Pharmaceuticals . AMPH Amphastar P OGN Organon

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Jason Mccarthy (MAXIM GROUP)